相关实验视频
Updated: Feb 14, 2026

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.8K
探索炎症性肠病和慢性病之间的联系:全国数据库研究
Chloe Lahoud1, Ali Sohail1, Toni Habib1
1Department of Internal Medicine, Staten Island University Hospital, Northwell Health, New York, NY 10305, USA.
Journal of clinical medicine
|February 13, 2026
概括
炎症性肠病 (IBD) 患者患慢性病 (CKD) 的风险类似,无论他们患有克罗恩病 (CD) 还是性结肠炎 (UC). 然而,死亡率和住院时间等结果在患有CKD的CD和UC患者之间有所不同.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 胃肠病学 胃肠病学
- 流行病学 流行病学
背景情况:
- 炎症性肠病 (IBD) 与肠外并发症,特别是病有关.
- 现有的文献表明IBD患者患慢性病 (CKD) 的风险增加.
研究的目的:
- 评估IBD和CKD之间的关联.
- 确定IBD患者中CKD发展的特定风险因素.
- 为了比较克罗恩氏病 (CD) 和性结肠炎 (UC) 之间的CKD患病率和结果.
主要方法:
- 利用了国家住院样本 (NIS) 数据库 (2016-2020) 的数据,用于住院的IBD患者.
- 将患者分层分为克罗恩氏病 (CD) 和性结肠炎 (UC) 队列.
- 进行单变量和多变量分析以确定CKD流行率,危险因素,死亡率和停留时间.
主要成果:
- 鉴定了230,766名IBD患者 (63%CD,37%UC);148,498名患者在1:1匹配后被纳入.
- 在CD和UC患者中,CKD的患病率一致为7.2%.
- 与患有CKD的UC患者相比,患有CD的CKD患者的住院死亡率较低,住院时间较短.
结论:
- 在克罗恩氏病和性结肠炎中,CKD的患病率类似,但风险因素和结果有所不同.
- 患有CKD的CD和UC患者之间存在死亡率和住院时间的显著差异.
- 强调需要针对IBD患者,特别是患有UC的患者进行个性化的CKD风险监测和管理策略.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
1.2K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Inflammatory Bowel Disease I: Ulcerative Colitis
1.1K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.1K
Inflammatory Bowel Disease V: Surgical Management
652
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
652
Chronic Kidney Disease I: Introduction
768
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
768
Inflammatory Bowel Disease IV: Pharmacological Management
743
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
743
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
860
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
860

